Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$1.37 - $7.24 $27,400 - $144,800
20,000 New
20,000 $142,000
Q3 2021

Oct 14, 2021

SELL
$17.57 - $28.95 $439,250 - $723,750
-25,000 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$24.14 - $37.68 $603,500 - $942,000
25,000 New
25,000 $725,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $55.1M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Reliant Investment Management, LLC Portfolio

Follow Reliant Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reliant Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reliant Investment Management, LLC with notifications on news.